
Menopause Supplement Market Report 2026
Global Outlook – By Product Type (Hormonal supplements, Non-hormonal supplements, Nutritional supplements, Other Product Types), By Form (Tablets, Capsules, Liquids, Powders, Gummies, Soft gels), By Gender (Women, Men), By Sales Channel (Store-based, Modern trade, Hospital pharmacies, Retail pharmacies, Drug stores, Online pharmacies), By End-user (Hospitals, Homecare, Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Menopause Supplement Market Overview
• Menopause Supplement market size has reached to $2.05 billion in 2025 • Expected to grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Rising Prevalence Of Menopausal Symptoms Fueling The Growth Of The Market Due To Longer Life Expectancy And Increased Postmenopausal Population • Market Trend: Natural, Personalized Supplementation Redefines Menopause Wellness • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Menopause Supplement Market?
A menopause supplement is a dietary formulation designed to support women experiencing hormonal changes during the menopausal transition by helping alleviate common symptoms such as hot flashes, mood swings, and sleep disturbances. These supplements promote hormonal balance and overall well-being. They are used to naturally enhance quality of life during menopause without acting as pharmaceutical hormone replacement therapy. The main product types of the menopause supplement market include hormonal supplements, non-hormonal supplements, nutritional supplements, and others. Hormonal supplements refer to formulations containing bioidentical or synthetic hormones such as estrogen, progesterone, or combinations thereof, designed to restore hormonal balance and alleviate symptoms associated with menopause, including hot flashes, mood swings, and night sweats. There are forms such as tablets, capsules, liquids, powders, gummies, and soft gels. The genders include women and men (with associated menopause-like conditions). The sales channels include store-based, modern trade, hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. The key end-users include hospitals, homecare, and clinics.
What Is The Menopause Supplement Market Size and Share 2026?
The menopause supplement market size has grown strongly in recent years. It will grow from $2.05 billion in 2025 to $2.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing awareness of menopause-related health management, rising preference for non-prescription wellness solutions, expansion of women’s health supplement offerings, growing health literacy among middle-aged women, availability of diverse supplement formats.What Is The Menopause Supplement Market Growth Forecast?
The menopause supplement market size is expected to see strong growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for personalized menopause nutrition, rising adoption of digital women’s health platforms, increasing focus on holistic and lifestyle-based menopause care, expansion of e-commerce supplement distribution, growing investment in female health research. Major trends in the forecast period include growing demand for natural hormone support solutions, rising adoption of non-hormonal supplement alternatives, expansion of symptom-specific menopause formulations, increased focus on women-centric wellness products, higher acceptance of preventive menopause care.Global Menopause Supplement Market Segmentation
1) By Product Type: Hormonal supplements, Non-hormonal supplements, Nutritional supplements, Other Product Types 2) By Form: Tablets, Capsules, Liquids, Powders, Gummies, Soft gels 3) By Gender: Women, Men 4) By Sales Channel: Store-based, Modern trade, Hospital pharmacies, Retail pharmacies, Drug stores, Online pharmacies 5) By End-user: Hospitals, Homecare, Clinics Subsegments: 1) By Hormonal Supplements: Estrogen Therapy, Progesterone Therapy, Combined Hormone Therapy, Bioidentical Hormone Therapy 2) By Non-Hormonal Supplements: Herbal Extract Supplements, Phytoestrogen Supplements, Homeopathic Supplements, Botanical Blend Supplements 3) By Nutritional Supplements: Vitamin Supplements, Mineral Supplements, Protein Supplements, Omega Fatty Acid Supplements 4) By Other Product Types: Probiotic Supplements, Collagen Supplements, Antioxidant Supplements, Enzyme SupplementsWhat Is The Driver Of The Menopause Supplement Market?
The rising prevalence of menopausal symptoms is expected to support the growth of the menopause supplement market going forward. Menopausal symptoms refer to the physical and emotional changes women experience due to declining estrogen levels during the transition to menopause. This prevalence is increasing as women live longer and spend a greater portion of their lives in the postmenopausal phase, leading to extended exposure to physical and hormonal changes. Menopause supplements are often used to help manage these symptoms by providing targeted nutrients and herbal compounds that may alleviate hot flashes, mood swings, and sleep disturbances, supporting overall hormonal balance and well-being, although usage varies among individuals. For instance, in December 2023, the National Library of Medicine, a U.S.-based government agency, reported that around 1.3 million women enter menopause annually, typically between ages 45 and 56, with 5% experiencing early menopause at 40–45 and 1% facing primary ovarian insufficiency before age 40. Therefore, the rising prevalence of menopausal symptoms is a key driver of growth in the menopause supplement industry.Key Players In The Global Menopause Supplement Market
Major companies operating in the menopause supplement market are Nestlé Health Science, Procter & Gamble, Bayer AG, Church & Dwight Co. Inc., Herbalife Nutrition Ltd., Amway Corporation, The Nature's Bounty Co., GNC Holdings Inc., Pharmavite LLC, Blackmores Limited, NOW Foods, Thorne HealthTech, Metagenics Inc., Jarrow Formulas Inc., Nature's Way, Vitabiotics Ltd., Standard Process Inc., Swisse Wellness Pty Ltd., Bio-Botanica Inc., Life ExtensionGlobal Menopause Supplement Market Trends and Insights
Major companies operating in the menopause supplement market are focusing on advanced innovation such as personalized supplements to provide targeted symptom relief, enhance efficacy, and meet the unique hormonal and nutritional needs of individual women. Personalized supplements refer to customized nutritional formulations designed based on an individual’s specific health needs, symptoms, hormones, or lifestyle factors. For instance, in September 2025, Desert Harvest, a US-based company known for developing natural health solutions, introduced its first menopause supplement featuring human-identical lactoferrin. This innovation marks a significant advancement, as the lactoferrin used closely mimics the form naturally found in the human body. The product is designed to support women during peri- and post-menopause by addressing issues such as hormonal imbalance, fatigue, and immune health. By combining bioidentical lactoferrin with natural ingredients, the company aims to offer a non-hormonal and science-backed alternative for menopause relief. This launch also signals Desert Harvest’s expansion into the rapidly growing women's health and menopause supplement market.What Are Latest Mergers And Acquisitions In The Menopause Supplement Market?
In June 2025, Hims & Hers Health, Inc., a US-based health and wellness platform specializing in personalized healthcare, acquired ZAVA for an undisclosed amount. Through this acquisition, Hims & Hers aims to expand its European presence and leverage ZAVA’s established digital platform and medical expertise to deliver personalized, high-quality healthcare across multiple markets. ZAVA is UK-based company aims to provide Test for the menopause, and get treatment for your symptoms.Regional Insights
North America was the largest region in the menopause supplement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Menopause Supplement Market?
The menopause supplement market consists of sales of magnesium supplements, omega-3 fish oil capsules, herbal tea blends for menopause, collagen powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Menopause Supplement Market Report 2026?
The menopause supplement market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the menopause supplement industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Menopause Supplement Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.21 billion |
| Revenue Forecast In 2035 | $2.98 billion |
| Growth Rate | CAGR of 7.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Form, Gender, Sales Channel, End-user |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Nestlé Health Science, Procter & Gamble, Bayer AG, Church & Dwight Co. Inc., Herbalife Nutrition Ltd., Amway Corporation, The Nature's Bounty Co., GNC Holdings Inc., Pharmavite LLC, Blackmores Limited, NOW Foods, Thorne HealthTech, Metagenics Inc., Jarrow Formulas Inc., Nature's Way, Vitabiotics Ltd., Standard Process Inc., Swisse Wellness Pty Ltd., Bio-Botanica Inc., Life Extension |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
